Dexamethasone-Conjugated Polyamidoamine Dendrimer for Delivery of the Heme Oxygenase-1 Gene into the Ischemic Brain

Macromolecular Bioscience

Volumn 15, Issue 7, 2015, Pages 1021-1028

  Jeon, Pureum ^a   Choi, Manbok ^a   Oh, Jungju ^a   Lee, Minhyung ^a  

^a Hanyang University   (South Korea)

Author keywords

dexamethasone; gene therapy; heme oxygenase 1; polyamidoamine; stroke

Indexed keywords

GENE THERAPY;

ANTI-INFLAMMATORY EFFECTS; DEXAMETHASONES; HEME OXYGENASE-1; HEME OXYGENASE-1 GENE; POLYAMIDOAMINE DENDRIMERS; POLYAMIDOAMINES; STROKE; THERAPEUTIC EFFECTS;

PORPHYRINS;

DENDRIMER; DEXAMETHASONE; HEME OXYGENASE 1; PLASMID DNA; POLYAMIDOAMINE; POLYETHYLENEIMINE; POLYAMINE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; COMPLEX FORMATION; CRITICAL MICELLE CONCENTRATION; GENE TARGETING; GENE THERAPY; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; THERAPY EFFECT; ANIMAL; BRAIN; DISEASE MODEL; DRUG EFFECTS; GENE TRANSFER; GENETICS; PLASMID; RAT;

ANIMALS; BRAIN; BRAIN ISCHEMIA; DENDRIMERS; DEXAMETHASONE; DISEASE MODELS, ANIMAL; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HEME OXYGENASE-1; MICE; PLASMIDS; POLYAMINES; RATS;

EID: 84948578565     PISSN: 16165187     EISSN: 16165195     Source Type: Journal    
DOI: 10.1002/mabi.201500058     Document Type: Article

References (16)

1. H. C. Kang, M. Lee, Y. H. Bae, Crit. Rev. Eukaryot. Gene Expr. 2005, 15, 317.
2. A. Rebuffat, A. Bernasconi, M. Ceppi, H. Wehrli, S. B. Verca, M. Ibrahim, B. M. Frey, F. J. Frey, S. Rusconi, Nat. Biotechnol. 2001, 19, 1155.
3. J. A. Gruneich, A. Price, J. Zhu, S. L. Diamond, Gene Ther. 2004, 11, 668.
4. J. S. Choi, K. S. Ko, J. S. Park, Y. H. Kim, S. W. Kim, M. Lee, Int. J. Pharm. 2006, 320, 171.
5. Y. M. Bae, H. Choi, S. Lee, S. H. Kang, Y. T. Kim, K. Nam, J. S. Park, M. Lee, J. S. Choi, Bioconjug. Chem. 2007, 18, 2029.
6. H. Kim, H. A. Kim, Y. M. Bae, J. S. Choi, M. Lee, J. Gene Med. 2009, 11, 515.
7. V. Shahin, L. Albermann, H. Schillers, L. Kastrup, C. Schafer, Y. Ludwig, C. Stock, H. Oberleithner, J. Cell. Physiol. 2005, 202, 591.
8. H. Hyun, J. Lee, W. Hwang do, S. Kim, D. K. Hyun, J. S. Choi, J. K. Lee, M. Lee, Biomaterials 2011, 32, 306.
9. H. A. Kim, J. H. Park, S. Lee, J. S. Choi, T. Rhim, M. Lee, J. Control. Release 2011, 156, 60.
10. U. I. Tuor, C. S. Simone, J. D. Barks, M. Post, Stroke 1993, 24, 452.
11. J. Y. Kim, J. H. Ryu, H. Hyun, H. A. Kim, J. S. Choi, D. Yun Lee, T. Rhim, J. H. Park, M. Lee, J. Drug Target. 2012, 20, 667.
12. A. S. Chauhan, P. V. Diwan, N. K. Jain, D. A. Tomalia, Biomacromolecules 2009, 10, 1195.
13. F. H. Bach, Wien Klin. Wochenschr. 2002, 114, 1.
14. H. Hyun, Y. W. Won, K. M. Kim, J. Lee, M. Lee, Y. H. Kim, Biomaterials 2010, 31, 9128.
15. M. Lee, S. Oh, C. H. Ahn, S. W. Kim, B. D. Rhee, K. S. Ko, J. Control. Release 2006, 115, 316.
16. G. F. Lemkine, D. Goula, N. Becker, L. Paleari, G. Levi, B. A. Demeneix, J. Drug Target. 1999, 7, 305.